$118 Million is the total value of Vida Ventures Advisors, LLC's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma, Inc. | $34,645,000 | +12.0% | 2,747,433 | 0.0% | 29.28% | +62.7% | |
| ALLO | Allogene Therapeutics, Inc. | $20,499,000 | +25.1% | 1,798,163 | 0.0% | 17.32% | +81.8% | |
| DYN | Dyne Therapeutics, Inc. | $20,335,000 | -28.7% | 2,960,046 | 0.0% | 17.18% | +3.5% | |
| CNTA | Centessa Pharmaceuticals plcordinary shares | $19,148,000 | -45.7% | 3,931,818 | 0.0% | 16.18% | -21.1% | |
| KRON | Kronos Bio, Inc. | $10,066,000 | -49.7% | 2,765,314 | 0.0% | 8.51% | -26.8% | |
| PRAX | Praxis Precision Medicines, Inc. | $7,201,000 | -76.0% | 2,939,329 | 0.0% | 6.08% | -65.1% | |
| LianBioordinary shares | $4,929,000 | -41.8% | 2,282,084 | 0.0% | 4.16% | -15.4% | ||
| FIXX | Homology Medicines, Inc. | $1,519,000 | -35.2% | 770,845 | 0.0% | 1.28% | -5.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-07-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Dyne Therapeutics, Inc. | 14 | Q4 2023 | 37.4% |
| Allogene Therapeutics, Inc. | 14 | Q4 2023 | 42.5% |
| Kinnate Biopharma, Inc. | 13 | Q4 2023 | 29.3% |
| Kronos Bio, Inc. | 13 | Q4 2023 | 20.4% |
| Praxis Precision Medicines, Inc. | 12 | Q3 2023 | 33.2% |
| Centessa Pharmaceuticals plc | 11 | Q4 2023 | 39.4% |
| LianBio | 9 | Q4 2023 | 12.1% |
| Homology Medicines, Inc. | 9 | Q3 2022 | 5.2% |
| Oyster Pt Pharma Inc | 5 | Q3 2021 | 10.3% |
| Assembly Biosciences, Inc. | 4 | Q2 2021 | 4.6% |
View Vida Ventures Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-01-05 |
| 13F-HR | 2023-10-03 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-04-13 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-10-05 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-10 |
View Vida Ventures Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.